Cargando…
Evaluation of chemosensitivity prediction using quantitative dose–response curve classification for highly advanced/relapsed gastric cancer
BACKGROUND: The use of standard chemotherapy regimens has changed the application of chemosensitivity tests from all chemotherapy-eligible patients to those who have failed standard chemotherapy, which includes patients with highly advanced, relapsed, or chemoresistant tumors. METHODS: We evaluated...
Autores principales: | Matsuo, Teppei, Nishizuka, Satoshi S, Ishida, Kazushige, Endo, Fumitaka, Katagiri, Hirokatsu, Kume, Kohei, Ikeda, Miyuki, Koeda, Keisuke, Wakabayashi, Go |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562164/ https://www.ncbi.nlm.nih.gov/pubmed/23339659 http://dx.doi.org/10.1186/1477-7819-11-11 |
Ejemplares similares
-
A Compensatory Role of NF-κB to p53 in Response to 5-FU–Based Chemotherapy for Gastric Cancer Cell Lines
por: Endo, Fumitaka, et al.
Publicado: (2014) -
Molecular Marker Identification for Relapse Prediction in 5-FU-Based Adjuvant Chemotherapy in Gastric and Colorectal Cancers
por: Ishida, Kazushige, et al.
Publicado: (2012) -
α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15
por: Kume, Kohei, et al.
Publicado: (2016) -
Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models
por: Matsuo, Teppei, et al.
Publicado: (2011) -
Laparoendoscopic single site adrenalectomy: initial results of cosmetic satisfaction and the potential for postoperative pain reduction
por: Sasaki, Akira, et al.
Publicado: (2013)